Literature DB >> 15326297

Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.

D Borden Lacy1, Darran J Wigelsworth, Roman A Melnyk, Stephen C Harrison, R John Collier.   

Abstract

After binding to cellular receptors and proteolytic activation, the protective antigen component of anthrax toxin forms a heptameric prepore. The prepore later undergoes pH-dependent conversion to a pore, mediating translocation of the edema and lethal factors to the cytosol. We describe structures of the prepore (3.6 A) and a prepore:receptor complex (4.3 A) that reveal the location of pore-forming loops and an unexpected interaction of the receptor with the pore-forming domain. Lower pH is required for prepore-to-pore conversion in the presence of the receptor, indicating that this interaction regulates pH-dependent pore formation. We present an example of a receptor negatively regulating pH-dependent membrane insertion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326297      PMCID: PMC516539          DOI: 10.1073/pnas.0405405101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Structural basis of collagen recognition by integrin alpha2beta1.

Authors:  J Emsley; C G Knight; R W Farndale; M J Barnes; R C Liddington
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Point mutations in anthrax protective antigen that block translocation.

Authors:  B R Sellman; S Nassi; R J Collier
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

3.  Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin.

Authors:  J Mogridge; M Mourez; R J Collier
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

4.  PA63 channel of anthrax toxin: an extended beta-barrel.

Authors:  Shilla Nassi; R John Collier; Alan Finkelstein
Journal:  Biochemistry       Date:  2002-02-05       Impact factor: 3.162

5.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

6.  Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein.

Authors:  W Mothes; A L Boerger; S Narayan; J M Cunningham; J A Young
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

7.  Anthrax protective antigen: prepore-to-pore conversion.

Authors:  C J Miller; J L Elliott; R J Collier
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

8.  Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.

Authors:  M Varughese; A V Teixeira; S Liu; S H Leppla
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  Identification of the cellular receptor for anthrax toxin.

Authors:  K A Bradley; J Mogridge; M Mourez; R J Collier; J A Young
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

10.  Characterization of membrane translocation by anthrax protective antigen.

Authors:  J Wesche; J L Elliott; P O Falnes; S Olsnes; R J Collier
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

View more
  122 in total

1.  Supercharging protein complexes from aqueous solution disrupts their native conformations.

Authors:  Harry J Sterling; Alexander F Kintzer; Geoffrey K Feld; Catherine A Cassou; Bryan A Krantz; Evan R Williams
Journal:  J Am Soc Mass Spectrom       Date:  2011-12-13       Impact factor: 3.109

2.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

3.  Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel.

Authors:  Sen Zhang; Alan Finkelstein; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

Review 4.  Ratcheting up protein translocation with anthrax toxin.

Authors:  Geoffrey K Feld; Michael J Brown; Bryan A Krantz
Journal:  Protein Sci       Date:  2012-03-30       Impact factor: 6.725

5.  Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.

Authors:  Rebecca A Brady; Anita Verma; Bruce D Meade; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

6.  An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans.

Authors:  Rebecca J Ingram; Karen K Chu; Gökhan Metan; Bernard Maillere; Mehmet Doganay; Yusuf Ozkul; Hugh Dyson; E Diane Williamson; Les Baillie; Louise U Kim; Stephanie Ascough; Shiranee Sriskandan; Daniel M Altmann
Journal:  Infect Immun       Date:  2010-05       Impact factor: 3.441

7.  Atomic Structures of Anthrax Prechannel Bound with Full-Length Lethal and Edema Factors.

Authors:  Kang Zhou; Shiheng Liu; Nathan J Hardenbrook; Yanxiang Cui; Bryan A Krantz; Z Hong Zhou
Journal:  Structure       Date:  2020-06-09       Impact factor: 5.006

8.  Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.

Authors:  Sherry R Crowe; Lori Garman; Renata J M Engler; A Darise Farris; Jimmy D Ballard; John B Harley; Judith A James
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

9.  Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.

Authors:  Maheshinie Rajapaksha; Jack F Eichler; Jan Hajduch; David E Anderson; Kenneth L Kirk; James G Bann
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

10.  Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor.

Authors:  Shilpi Sharma; Diane Thomas; John Marlett; Marianne Manchester; John A T Young
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.